Imaging techniques in IBD and their role in follow-up and surveillance

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 12, 2014, Pages 722-736

  Eliakim, Rami ^a   Magro, Fernando ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b Institute of Pharmacology and Therapeutics   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; INDIUM 111; SUCCIMER; TECHNETIUM 99M;

CHROMOENDOSCOPY; COMPUTED TOMOGRAPHY ENTEROGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONFOCAL LASER MICROSCOPY; CONTRAST ENHANCEMENT; DEVICE ASSISTED ENTEROSCOPY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; DOPPLER ECHOGRAPHY; ECHOGRAPHY; ENDOCYTOSCOPY; ENDOSCOPY; FOLLOW UP; HEPATITIS; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE ENDOSCOPY; LIVER FIBROSIS; LIVER SURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EDUCATION; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; RISK REDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CAPSULE ENDOSCOPY; FIBROSIS; GASTROINTESTINAL ENDOSCOPY; INFLAMMATORY BOWEL DISEASES; INTESTINE; PATHOLOGY; PROCEDURES; RECURRENT DISEASE;

CAPSULE ENDOSCOPY; ENDOSCOPY, GASTROINTESTINAL; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MAGNETIC RESONANCE IMAGING; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84927130182     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.144     Document Type: Review

References (144)

1. Parente, F. et al. Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn's disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy. Gut 53, 1652-1657 (2004).
2. Panes, J. et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment. Pharmacol. Ther. 34, 125-145 (2011).
3. Ripolles, T. et al. Crohn Disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 253, 241-248 (2009).
4. Futagami, Y. et al. Development and validation of an ultrasonographic activity index of Crohn's disease. Eur. J. Gastroenterol. Hepatol. 11, 1007-1012 (1999).
5. Haber, H. P. et al. Ultrasonographic findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides. J. Ultrasound Med. 21, 375-382 (2002).
6. Bremner, A. R., Griffiths, M., Argent, J. D., Fairhurst, J. J. & Beattie, R. M. Sonographic evaluation of inflammatory bowel disease: a prospective, blinded, comparative study. Pediatr. Radiol. 36, 947-953 (2006).
7. Parente, F. et al. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment. Pharmacol. Ther. 18, 1009-1016 (2003).
8. Panes, J. et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J. Crohns Colitis 7, 556-585 (2013).
9. Fraquelli, M. et al. Role of US in detection of Crohn disease: meta-analysis. Radiology 236, 95-101 (2005).
10. Martinez, M. J., Ripolles, T., Paredes, J. M., Blanc, E. & Marti-Bonmati, L. Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI. Abdom. Imaging 34, 141-148 (2009).
11. Rimola, J., Ordas, I., Rodriguez, S., Ricart, E. & Panes, J. Imaging indexes of activity and severity for Crohn's disease: current status and future trends. Abdom. Imaging 37, 958-966 (2012).
12. Calabrese, E. et al. Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease. J. Crohns Colitis 6, 852-860 (2012).
13. Xu, H.-X. Contrast-enhanced ultrasound: the evolving applications. World J. Radiol. 1, 15-24 (2009).
14. Migaleddu, V., Quaia, E., Scano, D. & Virgilio, G. Inflammatory activity in Crohn disease: ultrasound findings. Abdom. Imaging 33, 589-597 (2008).
15. Quaia, E. et al. The value of small bowel wall contrast enhancement after sulfur hexafluoride-filled microbubble injection to differentiate inflammatory from fibrotic strictures in patients with Crohn's disease. Ultrasound Med. Biol. 38, 1324-1332 (2012).
16. Malago, R. et al. Contrast-enhanced ultrasonography (CEUS) vs. MRI of the small bowel in the evaluation of Crohn's disease activity. Radiol. Med. 117, 268-281 (2012).
17. Girlich, C., Schacherer, D., Jung, E. M., Schreyer, A. & Buettner, R. Comparison between a clinical activity index (Harvey-Bradshaw-Index), laboratory inflammation markers and quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound in Crohn's disease. Eur. J. Radiol. 81, 1105-1109 (2012).
18. Ripolles, T. et al. Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohn's disease and other abdominal conditions. Eur. J. Radiol. 82, E525-E531 (2013).
19. Thomson, M., Rao, P., Berger, L. & Rawat, D. Graded compression and power Doppler ultrasonography versus endoscopy to assess paediatric Crohn disease activity pre-and posttreatment. J. Pediatr. Gastroenterol. Nutr. 54, 404-408 (2012).
20. Kruschewski, M., Busch, C., Dorner, A. & Lierse, W. Vascular architecture of the colon in Crohns disease and ulcerative colitis-light-microscopy and scanning electron-microscopy study with special reference to the morphology of the normal colon. Langenbecks Archiv. Fur Chirurgie. 380, 253-259 (1995).
21. Nylund, K. et al. Quantitative contrast-enhanced ultrasound comparison between inflammatory and fibrotic lesions in patients with Crohn's disease. Ultrasound Med. Biol. 39, 1197-1206 (2013).
22. Ripolles, T. et al. Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn's disease: a comparison with surgical histopathology analysis. J. Crohns Colitis 7, 120-128 (2013).
23. Kim, K. et al. Noninvasive ultrasound elasticity imaging (UEI) of Crohn's disease: animal model. Ultrasound Med. Biol. 34, 902-912 (2008).
24. Stidham, R. W. et al. Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn's disease. Gastroenterology 141, 819-826 (2011).
25. Calabrese, E. et al. severity of postoperative recurrence in Ccrohn's disease: correlation between endoscopic and sonographic findings. Inflamm. Bowel Dis. 15, 1635-1642 (2009).
26. Rispo, A. et al. Bowel sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm. Bowel Dis. 12, 486-490 (2006).
27. Castiglione, F. et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm. Bowel Dis. 14, 1240-1245 (2008).
28. Paredes, J. M. et al. Non-invasive diagnosis and grading of postsurgical endoscopic recurrence in Crohn's disease: usefulness of abdominal ultrasonography and 99mTc-hexamethylpropylene amineoxime-labelled leucocyte scintigraphy. J. Crohns Colitis 4, 537-545 (2010).
29. Paredes, J. M. et al. Contrast-enhanced ultrasonography: usefulness in the assessment of postoperative recurrence of Crohn's disease. J. Crohns Colitis 7, 191-201 (2013).
30. Cammarota, T. et al. Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease. Scand. J. Gastroenterol. 48, 552-555 (2013).
31. Maconi, G. et al. Preoperative characteristics and postoperative behavior of bowel wall on risk of recurrence after conservative surgery in Crohn's disease-a prospective study. Ann. Surg. 233, 345-352 (2001).
32. Siddiki, H. A. et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am. J. Roentgenol. 193, 113-121 (2009).
33. Jensen, M. D., Ormstrup, T., Vagn-Hansen, C., Ostergaard, L. & Rafaelsen, S. R. Interobserver and intermodality agreement for detection of small bowel Crohn's disease with MR enterography and CT enterography. Inflamm. Bowel Dis. 17, 1081-1088 (2011).
34. Maglinte, D. D. T., Sandrasegaran, K., Lappas, J. C. & Chiorean, M. CT enteroclysis. Radiology 245, 661-671 (2007).
35. Engin, G. Computed tomography enteroclysis in the diagnosis of intestinal diseases. J. Comput. Assist. Tomogr. 32, 9-16 (2008).
36. Mazzeo, S. et al. Multidetector CT of the small bowel: evaluation after oral hyperhydration with isotonic solution. Radiologia Medica 109, 516-526 (2005).
37. Minordi, L. M., Vecchioli, A., Mirk, P. & Bonomo, L. CT enterography with polyethylene glycol solution vs CT enteroclysis in small bowel disease. Br. J. Radiol. 84, 112-119 (2011).
38. Hassan, C., Cerro, P., Zullo, A., Spina, C. & Morini, S. Computed tomography enteroclysis in comparison with ileoscopy in patients with Crohn's disease. Int. J. Colorectal Dis. 18, 121-125 (2003).
39. Andersen, K. et al. Multi-detector CT-colonography in inflammatory bowel disease: prospective analysis of CT-findings to high-resolution video colonoscopy. Eur. J. Radiol. 58, 140-146 (2006).
40. Bodily, K. D. et al. Crohn disease: Mural attenuation and thickness at contrast-enhanced CT enterography-correlation with endoscopic and histologic findings of inflammation. Radiology 238, 505-516 (2006).
41. Solem, C. A. et al. Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest. Endosc. 68, 255-266 (2008).
42. Chiorean, M. V. et al. Correlation of CT enteroclysis with surgical pathology in Crohn's disease. Am. J. Gastroenterol. 102, 2541-2550 (2007).
43. Tong, J. L. et al. Computed tomography enterography versus balloon-assisted enteroscopy for evaluation of small bowel lesions in Crohn's disease. J. Gastroenterol. Hepatol. 28, 1180-1186 (2013).
44. Lee, S. S. et al. CT of prominent pericolic or perienteric vasculature in patients with Crohn's disease: correlation with clinical disease activity and findings on barium studies. AJR Am. J. Roentgenol. 179, 1029-1036 (2002).
45. Wu, Y.-W., Tao, X.-F., Tang, Y.-H., Hao, N.-X. & Miao, F. Quantitative measures of comb sign in Crohn's disease: correlation with disease activity and laboratory indications. Abdom. Imaging 37, 350-358 (2012).
46. Pariente, B. et al. Development of the Crohn's Disease Digestive Damage Score, the Lemann Score. Inflamm. Bowel Dis. 17, 1415-1422 (2011).
47. Samuel, S. et al. Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy. Clin. Gastroenterol. Hepatol. 10, 1253-1259 (2012).
48. Maconi, G. et al. Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study. Am. J. Gastroenterol. 98, 1545-1555 (2003).
49. Adler, J. et al. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease. Inflamm. Bowel Dis. 18, 849-856 (2012).
50. Hara, A. K. & Swartz, P. G. CT enterography of Crohn's disease. Abdom. Imaging. 34, 289-295 (2009).
51. Hara, A. K. et al. Iterative reconstruction technique for reducing body radiation dose at CT: feasibility study. AJR Am. J. Roentgenol. 193, 764-771 (2009).
52. Prakash, P. et al. Reducing abdominal CT radiation dose with adaptive statistical iterative reconstruction technique. Invest. Radiol. 45, 202-210 (2010).
53. Kambadakone, A. R. et al. Low-dose MDCT and CT enterography of patients with Crohn disease: feasibility of adaptive statistical iterative reconstruction. AJR Am. J. Roentgenol. 196, W743-W752 (2011).
54. Hardie, A. D., Horst, N. D. & Mayes, N. Preliminary evaluation of ultra-high pitch computed tomography enterography. Acta Radiologica 53, 1088-1091 (2012).
55. Guimaraes, L. S. et al. Feasibility of dose reduction using novel denoising techniques for low kV (80 kV) CT enterography: optimization and validation. Acad. Radiology 17, 1203-1210 (2010).
56. Lee, S. J. et al. A prospective comparison of standard-dose CT enterography and 50% reduced-dose CT enterography with and without noise reduction for evaluating Crohn disease. AJR Am. J. Roentgenol. 197, 50-57 (2011).
57. O'Neill, S. B. et al. A prospective feasibility study of sub-millisievert abdominopelvic CT using iterative reconstruction in Crohn's disease. Eur. Radiol. 23, 2503-2512 (2013).
58. Paparo, F. et al. Crohn's disease: prevalence of intestinal and extraintestinal manifestations detected by computed tomography enterography with water enema. Abdom. Imaging. 37, 326-337 (2012).
59. Soyer, P. et al. Small bowel adenocarcinoma in Crohn disease: CT-enterography features with pathological correlation. Abdom. Imaging 37, 338-349 (2012).
60. Malgras, B. et al. Accuracy of imaging for predicting operative approach in Crohn's disease. Br. J. Surg. 99, 1011-1020 (2012).
61. Soyer, P. et al. Suspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysis. Radiology 254, 755-764 (2010).
62. Paparo, F. et al. Crohn's disease recurrence in patients with ileocolic anastomosis: value of computed tomography enterography with water enema. Eur. J. Radiol. 82, E434-E440 (2013).
63. Mao, R. et al. CT enterography in evaluating postoperative recurrence of Crohn's disease after ileocolic resection: complementary role to endoscopy. Inflamm. Bowel Dis. 19, 977-982 (2013).
64. Hara, A. K. et al. Using CT enterography to monitor Crohn's disease activity: a preliminary study. AJR Am. J. Roentgenol. 190, 1512-1516 (2008).
65. Wu, Y. W., Tang, Y. H., Hao, N. X., Tang, C. Y., Miao, F. Crohn's disease: CT enterography manifestations before and after treatment. Eur. J. Radiol. 81, 52-59 (2012).
66. Bruining, D. H. et al. Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn's disease. Clin. Gastroenterol. Hepatol. 9, 679-683 (2011).
67. Bruining, D. H. & Loftus, E. V. Jr. Technology Insight: new techniques for imaging the gut in patients with IBD. Nat. Clin. Pract Gastroenterol. Hepatol. 5, 154-161 (2008).
68. Cipriano, L. E., Levesque, B. G., Zaric, G. S., Loftus, E. V. Jr & Sandborn, W. J. Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease. Inflamm. Bowel Dis. 18, 1240-1248 (2012).
69. Rieber, A., Nussle, K., Reinshagen, M., Brambs, H. J. & Gabelmann, A. MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease. Abdom. Imaging 27, 394-399 (2002).
70. Lauenstein, T. C. et al. Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228, 279-283 (2003).
71. Fidler, J. L., Guimaraes, L. & Einstein, D. M. MR imaging of the small bowel. Radiographics 29, 1811-1826 (2009).
72. Horsthuis, K., Bipat, S., Stokkers, P. C. F. & Stoker, J. Magnetic resonance imaging for evaluation of disease activity in Crohn's disease: a systematic review. Eur. Radiol. 19, 1450-1460 (2009).
73. Maccioni, F. et al. MR imaging in patents with Crohn disease: value of T2-versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 238, 517-530 (2006).
74. Masselli, G. & Gualdi, G. MR imaging of the small bowel. Radiology 264, 333-348 (2012).
75. Rimola, J. et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm. Bowel Dis. 17, 1759-1768 (2011).
76. Gourtsoyiannis, N. et al. Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur. Radiol. 14, 1017-1024 (2004).
77. Steward, M. J. et al. Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur. J. Radiol. 81, 2080-2088 (2012).
78. Fiorino, G. et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm. Bowel Dis. 17, 1073-1080 (2011).
79. Rimola, J. et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 58, 1113-1120 (2009).
80. Buisson, A. et al. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease. Aliment. Pharmacol. Ther. 37, 537-545 (2013).
81. Ream, J. M. et al. MRI diffusion-weighted imaging (DWI) in pediatric small bowel Crohn disease: correlation with MRI findings of active bowel wall inflammation. Pediatr. Radiol. 43, 1077-1085 (2013).
82. Oto, A. et al. Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J. Magn. Reson. Imaging 33, 615-624 (2011).
83. Hordonneau, C. et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity. Am. J. Gastroenterol. 109, 89-98 (2014).
84. Bickelhaupt, S. et al. Crohn's disease: small bowel motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin. Neurogastroenterol. Motil. 25, 467-473 (2013).
85. Bickelhaupt, S. et al. Differentiation between active and chronic Crohn's disease using MRI small-bowel motility examinations-initial experience. Clin. Radiol. 68, 1247-1253 (2013).
86. Maccioni, F., Staltari, I., Pino, A. R. & Tiberti, A. Value of T2-weighted magnetic resonance imaging in the assessment of wall inflammation and fibrosis in Crohn's disease. Abdom. Imaging 37, 944-957 (2012).
87. Punwani, S. et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 252, 712-720 (2009).
88. Breynaert, C. et al. Unique gene expression and MR T-2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease. PLoS ONE 8, e68876 (2013).
89. Adler, J. et al. Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 259, 127-135 (2011).
90. Larsson, A. E. et al. Magnetic resonance imaging of experimental mouse colitis and association with inflammatory activity. Inflamm. Bowel Dis. 12, 478-485 (2006).
91. Mustafi, D. et al. High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis. Magn. Reson. Med. 63, 922-929 (2010).
92. Pazahr, S. et al. Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn's disease: initial experience. Magn. Reson. Mat. Phys. Biol. Med. 26, 291-301 (2013).
93. Menys, A. et al. Small bowel strictures in Crohn's disease: a quantitative investigation of intestinal motility using MR enterography. Neurogastroenterol. Motil. 25, 967-e775 (2013).
94. Van Assche, G. et al. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease. J. Crohns Colitis 7, 950-957 (2013).
95. Ordás, I. et al. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. Gastroenterology 146, 374-382 (2014).
96. Cheriyan, D. G. et al. Impact of magnetic resonance enterography in the management of small bowel Crohn's disease. Eur. J. Gastroenterol. Hepatol. 25, 550-555 (2013).
97. Sailer, J. et al. Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur. Radiol. 18, 2512-2521 (2008).
98. Koilakou, S. et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Inflamm. Bowel Dis. 16, 198-203 (2010).
99. Basu, S. et al. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin. Nucl. Med. 39, 124-145 (2009).
100. Gotthardt, M., Bleeker-Rovers, C. P., Boerman, O. C. & Oyen, W. J. G. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J. Nucl. Med. 51, 1937-1949 (2010).
101. ICRP. Annex C Biokinetic models and dose tables. Ann. ICRP 38, 51-162 (2008).
102. Love, C. & Palestro, C. J. Radionuclide imaging of inflammation and infection in the acute care setting. Semin. Nucl. Med. 43, 102-113 (2013).
103. Lee, B. F. et al. Use of Tc-99m (V) DMSA scintigraphy in the detection and localization of intestinal inflammation: comparison of findings at colonoscopy and biopsy. Radiology 220, 381-385 (2001).
104. Koutroubakis, I. E. et al. Active inflammatory bowel disease: Evaluation with 99mTc (V) DMSA scintigraphy. Radiology 229, 70-74 (2003).
105. Stathaki, M. I. et al. Active inflammatory bowel disease: head-to-head comparison between Tc-99m-hexamethylpropylene amine oxime white blood cells and Tc-99m(V)-dimercaptosuccinic acid scintigraphy. Nucl. Med. Commun. 29, 27-32 (2008).
106. Ercan, M. T. et al. Evaluation of Tc-99m(V) DMSA for imaging inflammatory lesions: an experimental study. Ann. Nucl. Med. 10, 419-423 (1996).
107. Papantoniou, V. et al. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Breast Cancer Res. 7, R33-R45 (2005).
108. Bai, L., Collins, J. F. & Ghishan, F. K. Cloning and characterization of a type IIINa-dependent phosphate cotransporter from mouse intestine. Am. J. Physiol. Cell Physiol. 279, C1135-C1143 (2000).
109. Spier, B. J., Perlman, S. B. & Reichelderfer, M. FDG-PET in inflammatory bowel disease. Q. J. Nucl. Med. Mol. Imaging. 53, 64-71 (2009).
110. Halpenny, D. F., Burke, J. P., Lawlor, G. O. & O'Connell, M. Role of PET and combination PET/CT in the evaluation of patients with inflammatory bowel disease. Inflamm. Bowel Dis. 15, 951-958 (2009).
111. Perlman, S. B., Hall, B. S. & Reichelderfer, M. PET/CT Imaging of Inflammatory Bowel Disease. Semin. Nucl. Med. 43, 420-426 (2013).
112. Roca, M., de Vries, E. F. J., Jamar, F., Israel, O. & Signore, A. Guidelines for the labelling of leucocytes with In-111-oxine. Eur. J. Nucl. Med. Mol. Imaging 37, 835-841 (2010).
113. de Vries, E. F. J., Roca, M., Jamar, F., Israel, O. & Signore, A. Guidelines for the labelling of leucocytes with Tc-99m-HMPAO. Eur. J. Nucl. Med. Mol. Imaging 37, 842-848 (2010).
114. Watkinson, J. C. et al. Pharmacokinetics, biodistribution and dosimetry of Tc-99m(V)DMSA in humans with squamous-cell carcinoma. Nucl. Med. Commun. 11, 343-359 (1990).
115. Saboury, B., Torigian, D. A. & Alavi, A. Comment on: "FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging, version 1.0". Eur. J. Nucl. Med. Mol. Imaging 37, 1430-1431 (2010).
116. Biancone, L. et al. Technetium-99m-HMPAO labeled leukocyte single photon emission computerized tomography (SPECT) for assessing Crohn's disease extent and intestinal infiltration. Am. J. Gastroenterol. 100, 344-354 (2005).
117. Hillel, P. G., Lorenz, E., Metherall, P. & Tindale, W. B. Tc-99m white-cell imaging in inflammatory bowel disease: a comparison of planar versus SPECT. Nucl. Med. Commun. 32, 591-596 (2011).
118. Mariani, G. et al. A review on the clinical uses of SPECT/CT. Eur. J. Nucl. Med. Mol. Imaging 37, 1959-1985 (2010).
119. Yap, K. S., Patel, C. N., Chowdhury, F. U. & Scarsbrook, A. F. Less commonly used and emerging clinical applications of SPECT-CT in benign and malignant disease. Nucl. Med. Commun. 33, 808-818 (2012).
120. Bailey, D. L. & Willowson, K. P. An evidence-based review of quantitative SPECT imaging and potential clinical applications. J. Nucl. Med. 54, 83-89 (2013).
121. Dionisio, P. M. et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn's disease: a meta-analysis. Am. J. Gastroenterol. 105, 1240-1248 (2010).
122. Tukey, M., Pleskow, D., Legnani, P., Cheifetz, A. S. & Moss, A. C. The utility of capsule endoscopy in patients with suspected Crohn's disease. Am. J. Gastroenterol. 104, 2734-2739 (2009).
123. Annese, V. et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J. Crohn's Colitis 7, 982-1018 (2013).
124. Flamant, M. T. C. et al. The prevalence and outcome of jejunal lesions visualized by small bowel capsule endoscopy in Crohn's disease. Inflamm. Bowel Dis. 19, 1390-1396 (2013).
125. Park, S. K. et al. Long-term prognosis of the jejunal involvement of Crohn's disease. J. Clin. Gastroenterol. 400-408 (2013).
126. Beltrain, V. P. et al. Evaluation of postsurgical recurrence in Crohn's disease: a new indication for capsule endoscopy. Gastrointest. Endosc. 66, 533-540 (2007).
127. Bourreille, A. et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of post operative recurrence of Crohn's disease: a prospective study. Gut 55, 978-983 (2006).
128. Maunoury, V. et al. Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified). Inflamm. Bowel Dis. 13, 152-155 (2007).
129. Meister, T. et al. Colon capsule endoscopy versus standard colonoscopy in assessing disease activity in patients with ulcerative colitis: a prospective trial. Gastrointest. Endosc. 75, 641-646 (2012).
130. Sung, J. et al. The use of Pillcam Colon in assessing mucosal inflammation in ulcerative colitis: a multicenter study. Endoscopy 44, 754-758 (2012).
131. Schluender, S. J. et al. Does preoperative wireless endoscopic capsule predict long-term outcome after heal pouch-anal anastomosis (IPAA)? Gastroenterology 130, A214 (2006).
132. Rahmi, G. et al. Multicenter comparison of double-balloon enteroscopy and spiral enteroscopy. J. Gastroenterol. Hepatol. 28, 992-998 (2013).
133. Pasha, S. F. et al. Double-balloon enteroscopy and capsule endoscopy have comparable diagnostic yield in small-bowel disease: a meta-analysis. Clin. Gastroenterol. Hepatol. 6, 671-676 (2008).
134. Esaki, M., Kubokura, T., Kudo, T. & Matsumoto, T. Endoscopic findings under narrow band imaging in ulcerative colitis. Dig. Endosc. 23, 140-142 (2011).
135. Hurlstone, D. P. et al. The role of high-magnificationchromoscopic colonoscopy in hereditary nonpolyposis colorectal cancer screening: a prospective "back-to-back" endoscopic study. Am. J. Gastroenterol. 100, 2167-2173 (2005).
136. Wu, L., Li, P., Wu, J., Cao, Y. & Gao, F. The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials. Colorectal Dis. 14, 416-420 (2012).
137. Pellisé, M. et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest. Endosc. 74, 840-848 (2011).
138. Kiesslich, R. et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 132, 874-882 (2007).
139. Kiesslich, R. et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 61, 1146-1153 (2012).
140. Buda, A. et al. Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: A pilot study. J. Crohns Colitis 8, 304-311 (2013).
141. Atreya, R. et al. In vivo molecular imaging using fluorescent anti-TNF antibodies and confocal laser endomicroscopy predicts response to anti-TNF therapy in Crohn's disease. Gastroenterology 144, S85-S86 (2013).
142. Cipolletta, L. et al. Endocytoscopy can identify dysplasia in aberrant crypt foci of the colorectum: a prospective in vivo study. Endoscopy 41, 129-132 (2009).
143. Gralnek, I. M. et al. A prospective cohort study evaluating a novel colonoscopy platform featuring full-spectrum endoscopy. Endoscopy 45, 697-702 (2013).
144. Gralnek, I. M. et al. Standard forward-viewing colonoscopy versus full-spectrum endoscopy: an international, multicentre, randomised, tandem colonoscopy trial. Lancet Oncol. 15, 353-360 (2014).